[1]
“MicroRNA-146a Modulation by Targeted Lipid Nanoparticles to Treat Rheumatoid Arthritis: A Proof-of-Concept RCT”, LMJHCR, vol. 4, no. 1, pp. 1–9, Jun. 2026, doi: 10.61919/h1fggw78.